Full text is available at the source.
Abstract
Graphene-based nanomaterials may enhance the delivery of nucleic acid therapeutics in cancer immunotherapy.
- Tumor heterogeneity and immune suppression limit the effectiveness of current cancer immunotherapies.
- Graphene-based nanomaterials offer high surface area and adjustable surface chemistry, which could improve therapeutic delivery.
- These nanomaterials may possess properties that respond to specific stimuli, potentially increasing their utility in treatment.
Simplified